Cerebrospinal fluid (CSF) biomarkers remain the gold standard for fluid-biomarker-based diagnosis of Alzheimer's disease (AD) during life. Plasma biomarkers avoid lumbar puncture and allow repeated sampling. Changes of plasma phospho-tau-181 in AD are of comparable magnitude and seem to parallel the changes in CSF, may occur in preclinical or predementia stages of the disease, and may differentiate AD from other causes of dementia with adequate accuracy. Plasma phospho-tau-181 may offer a useful alternative to CSF phospho-tau determination, but work still has to be done concerning the optimal method of determination with the highest combination of sensitivity and specificity and cost-effect parameters.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405617 | PMC |
| http://dx.doi.org/10.3390/biomedicines10081879 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes.
Brain
October 2024
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
In animal models, brain neurodegeneration biomarkers drain into cervical lymph nodes (CLNs), and this drainage function is reduced with ageing. If this occurred in humans, CLNs may provide a readily accessible measure of this aspect of protein clearance. We tested this hypothesis in people using ultrasound-guided fine needle aspiration (FNA).
View Article and Find Full Text PDFPoor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE study.
J Neurol Neurosurg Psychiatry
October 2024
Department of Brain Sciences, Imperial College London, London, UK
Article Synopsis
- Traumatic brain injury (TBI) is prevalent among military personnel and is linked to an increased risk of dementia, with the ADVANCE-TBI study focusing on the neurological effects of major battlefield trauma using blood biomarkers like NfL and GFAP.
- The study involved 1,145 servicemen and veterans, where TBI was identified in 16.9% of those exposed to major trauma, revealing significant mental health issues such as depression, anxiety, and PTSD, alongside impaired mobility and quality of life.
- Elevated GFAP levels were found post-TBI, particularly in more severe cases, indicating a correlation with mental health challenges and increased unemployment, demonstrating the long-term impact of TBI on military personnel.
Dysregulation of Lipid Metabolism Serves as A Link Between Alzheimer's and Cardiovascular Disease, As Witnessed in A Cross-Sectional Study.
Aging Dis
July 2024
Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, 45071 Toledo, Spain.
Cardiovascular risk factors and established cardiovascular disease (CVD) increase the risk of suffering dementia of the Alzheimer's type (DAT). Here, we set out to define specific molecular profiles of CVD in patients with DAT to better understand its relationship, to unravel the mechanisms underlying the high risk of developing DAT in CVD patients and to define new markers of early disease. Plasma samples from patients with DAT, with and without CVD, were analyzed through a multiomics approach, with integration of metabolomics and proteomics datasets using the OmicsNet web-based tool.
View Article and Find Full Text PDFPrognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
J Alzheimers Dis
May 2024
Department of Radiology, Weill Cornell Medicine, Brain Health Imaging Institute, New York, NY, USA.
With the advent of therapeutics with potential to slow Alzheimer's disease progression the necessity of understanding the diagnostic value of plasma biomarkers is critical, not only for understanding the etiology and progression of Alzheimer's disease, but also for access and response to potentially disease modifying therapeutic agents. Multiple studies are currently assessing the sensitivity and specificity of plasma biomarkers in large cohorts such as the Alzheimer's Disease Neuroimaging Initiative. This study uses machine learning to predict the progression from mild cognitive impairment using plasma biomarkers in conjunction with well-established cerebrospinal fluid and imaging biomarkers of disease progression.
View Article and Find Full Text PDFThe impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study.
Alzheimers Res Ther
February 2024
Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Background: The blood-based biomarkers are approaching the clinical practice of Alzheimer's disease (AD). Chronic kidney disease (CKD) has a potential confounding effect on peripheral protein levels. It is essential to characterize the impact of renal function on AD markers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!